The StageBio team is looking forward to attending the STP 41st Annual Symposium Toxicologic Pathology of the Hematopoietic System in Austin, TX June 19-23 and we hope to see you there!
The StageBio team is looking forward to attending the STP 41st Annual Symposium Toxicologic Pathology of the Hematopoietic System in Austin, TX June 19-23 and we hope to see you there!
It is with great honor that we announce the promotion of Dr. Stephanie Shrader as Director of General Toxicologic Pathology at StageBio.
It is with great honor that we introduce Dr. Tracey Papenfuss as a Senior Pathologist at StageBio. We are happy to have her on the team and look forward to all she will accomplish!
The StageBio team is looking forward to exhibiting and attending the ARVO Annual Meeting & Expo in Denver, Colorado. The ARVO conference will provide attendees access to new research, educational and professional development programming and networking opportunities for anyone working in the area of eye and vision research.
StageBio StageBio is honored to introduce Ellen Humphrey as Chief People and Business Integration Officer to our team. We are happy to have her on board and look forward to all she will accomplish!
StageBio is honored to introduce Dr. Lauren Peiffer as a Pathologist to our team. We are happy to have her on board and look forward to all she will accomplish!
It is with great honor that we introduce Dr. Suresh Muthupalani as a Senior Pathologist at StageBio. We are happy to have him on the team and look forward to all he will accomplish!
The StageBio team is looking forward to attending the 2022 Society of Toxicology’s Annual Meeting and ToxExpo in San Diego in March - and we hope to see you there!
StageBio Announces Lori Ball has been appointed as new CEO for StageBio, who brings a history of global leadership in the life sciences industry. Ms Ball will succeed Tom Galati, former CEO and Founder of StageBio, who will remain an integral part of the board of directors. Ms Ball will begin her role January 18, 2022.
In a recent ACT 2021 Talking Tox webinar titled “Safety of E-Cigarette Products – A Toxicological Challenge,” I provided scientific guidance on pathology endpoints for inhalation studies. During my segment, I discussed the special planning necessary to optimize histopathology results when studying test articles dosed via the inhalation route (nose-only, head, or whole-body exposure).
513.204.4400
